Published in Hepatitis Weekly, October 3rd, 2005
According to recent research from the United States, "An extracorporeal bioartificial liver device has the potential to provide temporary hepatic support for patients with liver failure.
"Our goal was to optimize the flow environment for the cultured hepatocytes in a flat-plate bioreactor, specifically focusing on oxygen delivery using high medium flow rates while reducing the detrimental effects of the resulting shear stresses."
"We used photolithographic techniques to fabricate microgrooves onto the underlying glass substrate. The microgrooves,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.